Watertown's First Potential IPO since 2023, Remix's Positive Clinical Trial Results, and Triveni Jumps into the Eczema Market
Plus the initial dosing of Enanta and Avencell's Clinical Trials
Triveni's New Digs, 99 Coolidge's Tenant Bonanza, and Remix's FDA Fast Track Designation
Plus Addgenes' new partnership, and Neumora and Acrivon's cash flow updates
Labshares Expanding to Watertown
Neumora's Wegovy alternative, Dyno announces manufacturing pact, and more